Target Price | $19.90 |
Price | $2.00 |
Potential |
895.00%
register free of charge
|
Number of Estimates | 10 |
10 Analysts have issued a price target Relay Therapeutics Inc 2026 .
The average Relay Therapeutics Inc target price is $19.90.
This is
895.00%
register free of charge
$30.00
1,400.00%
register free of charge
$12.00
500.00%
register free of charge
|
|
A rating was issued by 12 analysts: 11 Analysts recommend Relay Therapeutics Inc to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Relay Therapeutics Inc stock has an average upside potential 2026 of
895.00%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 10.01 | 4.22 |
60.82% | 57.87% | |
EBITDA Margin | -3,798.30% | -9,302.33% |
159.38% | 144.91% | |
Net Margin | -3,955.18% | -8,678.90% |
115.91% | 119.43% |
11 Analysts have issued a sales forecast Relay Therapeutics Inc 2025 . The average Relay Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Relay Therapeutics Inc EBITDA forecast 2025. The average Relay Therapeutics Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Relay Therapeutics Inc Analysts have issued a net profit forecast 2025. The average Relay Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.36 | -2.18 |
15.41% | 7.63% | |
P/E | negative | |
EV/Sales | negative |
5 Analysts have issued a Relay Therapeutics Inc forecast for earnings per share. The average Relay Therapeutics Inc EPS is
This results in the following potential growth metrics and future valuations:
Relay Therapeutics Inc...
Analyst | Rating | Action | Date |
---|---|---|---|
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 07 2025 |
Stifel |
Locked
➜
Locked
|
Locked | Feb 27 2025 |
Goldman Sachs |
Locked
➜
Locked
|
Locked | Feb 27 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 14 2025 |
JMP Securities |
Locked
➜
Locked
|
Locked | Dec 12 2024 |
Leerink Partners |
Locked
➜
Locked
|
Locked | Dec 04 2024 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 04 2024 |
Analyst Rating | Date |
---|---|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 07 2025 |
Locked
Stifel:
Locked
➜
Locked
|
Feb 27 2025 |
Locked
Goldman Sachs:
Locked
➜
Locked
|
Feb 27 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 14 2025 |
Locked
JMP Securities:
Locked
➜
Locked
|
Dec 12 2024 |
Locked
Leerink Partners:
Locked
➜
Locked
|
Dec 04 2024 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 04 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.